BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY

Objective: A simple, straightforward, ultra-performance liquid chromatography (UPLC) with a fluorescence detector method was developed and validated to determine xanthorrhizol in rat plasma. This method was successfully applied to an oral pharmacokinetic study. Methods: Xanthorrhizol was separated u...

Full description

Bibliographic Details
Published in:International Journal of Applied Pharmaceutics
Main Author: Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
Format: Article
Language:English
Published: Innovare Academics Sciences Pvt. Ltd 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185128286&doi=10.22159%2fijap.2024v16i1.49340&partnerID=40&md5=e5d5282108fde70e46ef0a25ac6251d1
id 2-s2.0-85185128286
spelling 2-s2.0-85185128286
Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
2024
International Journal of Applied Pharmaceutics
16
1
10.22159/ijap.2024v16i1.49340
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185128286&doi=10.22159%2fijap.2024v16i1.49340&partnerID=40&md5=e5d5282108fde70e46ef0a25ac6251d1
Objective: A simple, straightforward, ultra-performance liquid chromatography (UPLC) with a fluorescence detector method was developed and validated to determine xanthorrhizol in rat plasma. This method was successfully applied to an oral pharmacokinetic study. Methods: Xanthorrhizol was separated using a C18 column in an isocratic mode using a mobile phase of acetonitril e: water (85:15 v/v) at a 0.4 ml/min flow rate. The fluorescence detector was set at 230 nm excitation and 320 nm emission wavelengths. The method was then applied in the pharmacokinetic study involving 12 Sprague-Dawley rats. Results: The developed bioanalytical methods were found to be linear in the range of 0.078–5 µg/ml with a correlation coefficient of r2 =0.999. The percentage recovery of xanthorrhizol was more than 95%, and the relative standard deviation was less than 2. These results indicate that the method is accurate and precise. The limit of detection (LOD) and limit of quantification (LOQ) of the technique were 0.123 µg/ml and 0.373 µg/ml, respectively. Furthermore, the stability studies demonstrated that xanthorrhizol is stable under various analytical conditions. The pharmacokinetic study revealed that the area under the curve (AUC) was 27.23±19.65 (µg. h/ml), the half-life (t 1/2) was 7.71±2.89 h, the mean residence time (MRT) was 13.86±4.06 h while the maximum concentration (Cmax) was 1.58±0.62 µg/ml, and the time to reach the maximum concentration (Tmax) was 1.33±0.20 h. Conclusion: The developed bioanalytical method was reliable and successfully met all validation criteria, making it a robust choice for quantifying xanthorrhizol. Therefore, it may be effectively utilized to determine xanthorrhizol in rat plasma following a pharmacokinetic study. © 2024 The Authors. Published by Innovare Academic Sciences Pvt Ltd.
Innovare Academics Sciences Pvt. Ltd
9757058
English
Article
All Open Access; Gold Open Access
author Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
spellingShingle Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
author_facet Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
author_sort Noviza D.; Julianto T.; Majeed A.B.A.; Hamid K.A.
title BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
title_short BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
title_full BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
title_fullStr BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
title_full_unstemmed BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
title_sort BIOANALYTICAL OF UPLC METHOD DEVELOPMENT AND VALIDATION OF XANTHORRIZOL AND ITS APPLICATION TO PHARMACOKINETIC STUDY
publishDate 2024
container_title International Journal of Applied Pharmaceutics
container_volume 16
container_issue 1
doi_str_mv 10.22159/ijap.2024v16i1.49340
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185128286&doi=10.22159%2fijap.2024v16i1.49340&partnerID=40&md5=e5d5282108fde70e46ef0a25ac6251d1
description Objective: A simple, straightforward, ultra-performance liquid chromatography (UPLC) with a fluorescence detector method was developed and validated to determine xanthorrhizol in rat plasma. This method was successfully applied to an oral pharmacokinetic study. Methods: Xanthorrhizol was separated using a C18 column in an isocratic mode using a mobile phase of acetonitril e: water (85:15 v/v) at a 0.4 ml/min flow rate. The fluorescence detector was set at 230 nm excitation and 320 nm emission wavelengths. The method was then applied in the pharmacokinetic study involving 12 Sprague-Dawley rats. Results: The developed bioanalytical methods were found to be linear in the range of 0.078–5 µg/ml with a correlation coefficient of r2 =0.999. The percentage recovery of xanthorrhizol was more than 95%, and the relative standard deviation was less than 2. These results indicate that the method is accurate and precise. The limit of detection (LOD) and limit of quantification (LOQ) of the technique were 0.123 µg/ml and 0.373 µg/ml, respectively. Furthermore, the stability studies demonstrated that xanthorrhizol is stable under various analytical conditions. The pharmacokinetic study revealed that the area under the curve (AUC) was 27.23±19.65 (µg. h/ml), the half-life (t 1/2) was 7.71±2.89 h, the mean residence time (MRT) was 13.86±4.06 h while the maximum concentration (Cmax) was 1.58±0.62 µg/ml, and the time to reach the maximum concentration (Tmax) was 1.33±0.20 h. Conclusion: The developed bioanalytical method was reliable and successfully met all validation criteria, making it a robust choice for quantifying xanthorrhizol. Therefore, it may be effectively utilized to determine xanthorrhizol in rat plasma following a pharmacokinetic study. © 2024 The Authors. Published by Innovare Academic Sciences Pvt Ltd.
publisher Innovare Academics Sciences Pvt. Ltd
issn 9757058
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809677886086447104